A new growth forecast report titled Cell & Gene Therapy Contract Research Organizations Market Size, Share, Industry Analysis Report By Type of Therapy (Gene Therapy, Cell Therapy), By Type of Manufacturing Service, By Cell and Gene Therapy Modality, By Therapeutic Area, and By End-User, By Region – Market Forecast, 2025–2034 introduced by Polaris Market Research represents...

The global cell therapy manufacturing market is undergoing a transformative evolution, propelled by groundbreaking advances in regenerative medicine, increased clinical application of cell-based therapies, and expanding investment in advanced therapy medicinal products (ATMPs). Valued at USD 5.68 billion in 2024, the market is forecast to grow at a remarkable CAGR of...

Polaris Market Research has announced the latest report, namely DNA Manufacturing Market Size, Share, Trends, & Industry Analysis Report By Type (Plasmid DNA, Synthetic DNA), By Grade, By Application, End Use, By Region – Market Forecast, 2025–2034, that examines the overall market condition both now and in the future. It provides comprehensive and accurate research on the DNA...

"Executive Summary Europe Lentiviral Vector Market Size, Share, and Competitive Landscape Data Bridge Market Research analyses that the market is growing with a CAGR of 16.9% in the forecast period of 2021 to 2028 and is expected to reach USD 322.41 million by 2028 An exceptional Europe Lentiviral Vector Market research document can be formulated well with the blend of top attributes...

The HIP Replacement Devices Market is on a steady growth trajectory, valued at USD 4,960.33 million in 2024 and projected to expand at a CAGR of 2.50% from 2025 to 2032. Hip replacement devices are crucial medical implants designed to replace damaged or arthritic hip joints, typically involving the femoral head and the acetabulum. With the rising prevalence of osteoarthritis, rheumatoid...

 According to a new report from Intel Market Research, the global Newborn Bovine Serum market was valued at USD 1.42 billion in 2025 and is projected to reach USD 2.68 billion by 2034, growing at a steady CAGR of 7.3% during the forecast period (2026-2034). This growth is fueled by expanding biopharmaceutical production, increasing cell culture...